Current Pharmacogenomics and Personalized Medicine
Title: Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health)
Volume: 9 Issue: 3
Author(s): Sanaa M. Kamal, Louise Warnich, Lynnette R. Ferguson, Sanjeeva Srivastava, Sandipan Ray, Denise Avard, Yann Joly, Michael Le Huynh, Madeline Page, Mario Masellis, Edward S. Dove, David Gurwitz and Vural Ozdemir
Affiliation:
Keywords: Africa, essential diagnostics model list, essential medicines, global public health, pharmacogenomics research funding and development aid, political determinants of health, postgenomics personalized medicine, women's health, Human Genome Sequence, Polymorphism
Export Options
About this article
Cite this article as:
M. Kamal Sanaa, Warnich Louise, R. Ferguson Lynnette, Srivastava Sanjeeva, Ray Sandipan, Avard Denise, Joly Yann, Le Huynh Michael, Page Madeline, Masellis Mario, S. Dove Edward, Gurwitz David and Ozdemir Vural, Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health), Current Pharmacogenomics and Personalized Medicine 2011; 9 (3) . https://dx.doi.org/10.2174/187569211796957511
DOI https://dx.doi.org/10.2174/187569211796957511 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ciprofloxacin Stress Proteome of the Extended-Spectrum β-lactamase Producing Escherichia coli from Slaughtered Pigs
Current Proteomics Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View
Current Cancer Drug Targets Quantificational Methylation Analysis of APC and AXIN2 in HBV-related Hepatocellular Carcinoma
Current Cancer Therapy Reviews Separation of Ginseng Active Ingredients and their Roles in Cancer Metastasis Supplementary Therapy
Current Drug Metabolism Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors
Current Pharmaceutical Design Clinical Trials of Targeted Alpha Therapy for Cancer
Reviews on Recent Clinical Trials Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status
Current Pharmaceutical Design Fungal Mediated Generation of Mammalian Metabolites of Fenofibrate and Enhanced Pharmacological Activity of the Main Metabolite Fenofibric Acid
Drug Metabolism Letters The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development
Current Bioactive Compounds Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
Current Pharmaceutical Design siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector
Current Pharmaceutical Design Versatile and Valuable Utilization of Amidohydrolase L-glutaminase in Pharma and Food industries: A Review
Current Drug Metabolism Cancer Therapy: Targeting Mitochondria and other Sub-cellular Organelles
Current Pharmaceutical Design Angiogenesis and Hypoxia in Glioblastoma: A Focus on Cancer Stem Cells
CNS & Neurological Disorders - Drug Targets MiRNA, a New Treatment Strategy for Pulmonary Fibrosis
Current Drug Targets Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy Src Kinase Inhibitors: An Update on Patented Compounds
Current Medicinal Chemistry Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Current Cancer Drug Targets Modulation of Huntington’s Disease in Drosophila
CNS & Neurological Disorders - Drug Targets